Hims & Hers stock (NYSE: HIMS) increased by 16% yesterday following its announcement about expanding into the treatment of menopause and perimenopause—a strategic shift indicating that the company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback